Healthcare

Oneview Healthcare (ASX:ONE) was among the closely watched ASX movers on 27 July 2026 as the market assessed renewed volatility in small-cap health technology. In delayed intraday trading, the share price fell 8.82% to AUD 0.16.

The broader Australian sharemarket advanced during the session on 27 July 2026, with 9 of 11 sectors trading higher, led by strong gains across gold miners, Information Technology and Materials. Energy was easily the weakest sector, down 3.93%, alongside a smaller decline in Utilities. …

The broader Australian sharemarket advanced during the session on 27 July 2026, with 9 of 11 sectors trading higher, led by strong gains across gold miners, Information Technology and Materials. Energy was easily the weakest sector, down 3.93%, alongside a smaller decline in Utilities. …

Lumos Diagnostics Holdings Ltd (ASX:LDX) has released its fourth-quarter FY2026 activities report, outlining higher full-year revenue, substantial growth in its FebriDx product business and continued progress in the U.S. commercial rollout of its rapid point-of-care diagnostic platform. The company also reported positive quarterly operating …

Botanix Pharmaceuticals Limited (ASX:BOT) reported further commercial progress for Sofdra during the June 2026 quarter, with prescriptions shipped increasing 25%, unaudited net revenue rising 45% and operating cash outflow falling by more than half compared with the previous quarter. The clinical dermatology company also …

Imricor Medical Systems, Inc. (ASX: IMR) has formally launched commercial operations in the United States after securing Rady Children’s Hospital–San Diego as the first U.S. hospital customer for its NorthStar interventional magnetic resonance mapping and guidance system. The hospital intends to use the technology …

Imugene Limited (ASX:IMU) has announced two significant developments for the company, with Managing Director and Chief Executive Officer Leslie Chong stepping down effective immediately for personal reasons while the company's lead cell therapy program, azer-cel, delivered another positive clinical update from its ongoing Phase …